1. Home
  2. DVA vs MTSI Comparison

DVA vs MTSI Comparison

Compare DVA & MTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • MTSI
  • Stock Information
  • Founded
  • DVA 1994
  • MTSI 1950
  • Country
  • DVA United States
  • MTSI United States
  • Employees
  • DVA N/A
  • MTSI N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • MTSI Semiconductors
  • Sector
  • DVA Health Care
  • MTSI Technology
  • Exchange
  • DVA Nasdaq
  • MTSI Nasdaq
  • Market Cap
  • DVA 10.9B
  • MTSI 9.2B
  • IPO Year
  • DVA 1995
  • MTSI 2012
  • Fundamental
  • Price
  • DVA $136.95
  • MTSI $136.99
  • Analyst Decision
  • DVA Hold
  • MTSI Strong Buy
  • Analyst Count
  • DVA 4
  • MTSI 9
  • Target Price
  • DVA $157.00
  • MTSI $130.00
  • AVG Volume (30 Days)
  • DVA 736.8K
  • MTSI 593.0K
  • Earning Date
  • DVA 08-05-2025
  • MTSI 07-31-2025
  • Dividend Yield
  • DVA N/A
  • MTSI N/A
  • EPS Growth
  • DVA 14.90
  • MTSI N/A
  • EPS
  • DVA 10.11
  • MTSI N/A
  • Revenue
  • DVA $12,968,524,000.00
  • MTSI $845,205,000.00
  • Revenue This Year
  • DVA $6.46
  • MTSI $33.87
  • Revenue Next Year
  • DVA $3.24
  • MTSI $12.63
  • P/E Ratio
  • DVA $13.41
  • MTSI N/A
  • Revenue Growth
  • DVA 5.11
  • MTSI 32.63
  • 52 Week Low
  • DVA $131.76
  • MTSI $84.00
  • 52 Week High
  • DVA $179.60
  • MTSI $152.50
  • Technical
  • Relative Strength Index (RSI)
  • DVA 44.92
  • MTSI 71.83
  • Support Level
  • DVA $134.64
  • MTSI $128.74
  • Resistance Level
  • DVA $138.26
  • MTSI $134.47
  • Average True Range (ATR)
  • DVA 2.71
  • MTSI 3.27
  • MACD
  • DVA 0.14
  • MTSI 0.31
  • Stochastic Oscillator
  • DVA 54.56
  • MTSI 95.61

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About MTSI MACOM Technology Solutions Holdings Inc.

MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.

Share on Social Networks: